#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16322	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2691	749.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1942	1942	T	1050	T,A,G,C	1044,3,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16322	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2691	749.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1676	1676	C	1068	C,T,A	1065,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28344	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3953	893.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1882	1882	A	1181	A,G	1180,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28344	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3953	893.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2516	2516	C	976	C,T	975,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28344	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3953	893.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2590	2590	A	930	A,G	929,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28344	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3953	893.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3142	3142	C	1022	C,G	1020,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	0	.	p	.	0	G5V	NONSYN	13	15	GGT	586	588	GTT	184;182;180	G;T,G;T	184;181,1;180	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	0	.	p	.	0	E12K	NONSYN	34	36	GAA	607	609	AAA	175;174;176	A;A;A,C	175;174;175,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	0	.	p	.	0	F31L	NONSYN	91	93	TTT	664	666	TTG	194;193;192	T;T;G	194;193;192	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	697	699	CAA	224;227;227	C;A;A	224;227;227	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	0	.	p	.	0	S75P	NONSYN	223	225	TCC	796	798	CCT	242;242;239	C,A;C,A;T,C,A	241,1;241,1;237,1,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	0	.	p	.	0	V87A	NONSYN	259	261	GTA	832	834	GCA	197;192;190	G;C,G;A	197;191,1;190	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	0	.	p	.	0	V130L	NONSYN	388	390	GTC	961	963	CTC	258;260;262	C,G;T;C	257,1;260;262	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	0	.	p	.	0	R135C	NONSYN	403	405	CGC	976	978	TGT	268;270;271	T;G;T	268;270;271	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	0	.	p	.	0	T137A	NONSYN	409	411	ACG	982	984	GCG	277;273;277	G;C,G;G	277;272,1;277	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1024	1026	AAG	277;276;276	A,G;A,T;G	276,1;275,1;276	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	0	.	p	.	0	T152N	NONSYN	454	456	ACC	1027	1029	AAT	277;279;281	A;A;T	277;279;281	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1225	1227	TTG	143;143;141	T;T;G	143;143;141	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1255	1257	AGC	142;142;140	A;G;C	142;142;140	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1324	1326	CTG	131;131;129	C;T;G	131;131;129	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1330	1332	TCC	123;124;125	T;C;C	123;124;125	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1345	1347	GTG	138;138;138	G;T;G,C	138;138;137,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1970	folP	852	852	93.78	folP.l15.c4.ctg.1	2009	122.3	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1396	1398	GCG	172;169;166	G;C;G	172;169;166	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6276	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3866	202.6	1	SNP	p	S91F	0	.	.	271	273	TCC	845	847	TCC	227;225;227	T;C;C	227;225;227	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6276	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3866	202.6	1	SNP	p	D95G	0	.	.	283	285	GAC	857	859	GAC	224;227;225	G;A,G;C	224;226,1;225	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6276	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3866	202.6	1	SNP	p	D95N	0	.	.	283	285	GAC	857	859	GAC	224;227;225	G;A,G;C	224;226,1;225	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	531	2264	mtrR	633	633	99.68	mtrR.l15.c30.ctg.1	1818	155.4	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	966	966	T	258	T,A	257,1	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1320	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1567	105.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5648	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3285	214.2	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1643	1645	ATC	266;266;269	A;T,A;C	266;265,1;269	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5648	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3285	214.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1796	1798	GCA	301;297;302	G;C;A	301;297;302	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5648	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3285	214.2	1	SNP	p	D86N	0	.	.	256	258	GAC	749	751	GAC	258;258;259	G;A;C,A	258;258;258,1	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5648	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3285	214.2	1	SNP	p	S87R	0	.	.	259	261	AGT	752	754	AGT	260;264;264	A,G;G,T;T,G	259,1;263,1;263,1	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5648	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3285	214.2	1	SNP	p	S87I	0	.	.	259	261	AGT	752	754	AGT	260;264;264	A,G;G,T;T,G	259,1;263,1;263,1	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5648	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3285	214.2	1	SNP	p	S87W	0	.	.	259	261	AGT	752	754	AGT	260;264;264	A,G;G,T;T,G	259,1;263,1;263,1	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5648	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3285	214.2	1	SNP	p	S88P	0	.	.	262	264	TCC	755	757	TCC	264;263;262	T,G;C;C	263,1;263;262	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5162	parE	1986	1986	99.95	parE.l15.c17.ctg.1	3023	212.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1740	1742	GGC	269;271;270	G,A;G;C	266,2;270;269	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2841	205.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1445	1447	GCA	261;265;262	G;C;A	261;265;262	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2841	205.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1448	1450	ATC	262;259;259	A;T;C	262;259;259	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2841	205.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1460	1462	GTG	262;262;264	G;T;G	262;262;264	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2841	205.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1460	1462	GTG	262;262;264	G;T;G	262;262;264	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2841	205.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1964	1966	ACC	276;277;276	A;C,T,G;C	276;275,1,1;276	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2841	205.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2018	2020	GCG	277;277;278	G,T,A;C,T;G	275,1,1;276,1;278	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2841	205.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2018	2020	GCG	277;277;278	G,T,A;C,T;G	275,1,1;276,1;278	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2841	205.4	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2141	2143	GGT	273;274;271	G;G;T	273;274;271	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2841	205.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2150	2152	GGC	267;267;268	G;G;C,T	267;267;266,2	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4682	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2841	205.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2168	2170	CCG	277;281;282	C,G;C;G,C	276,1;281;281,1	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6530	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3635	224.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2838	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2394	147.9	0	.	p	.	0	S22G	NONSYN	64	66	AGC	680	682	GGC	193;192;193	G;G;C	193;192;193	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2838	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2394	147.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	862	862	C	237	C	237	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	156	92.95	porB1a.l15.c17.ctg.2	156	45.7	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	27;31;32	T;T;A	27;31;32	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	156	92.95	porB1a.l15.c17.ctg.2	156	45.7	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	57;57;57	C;A;T	57;57;57	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	156	92.95	porB1a.l15.c17.ctg.2	156	45.7	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	57;57;57	A;G;T	57;57;57	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	156	92.95	porB1a.l15.c17.ctg.2	156	45.7	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	57;57;57	T;A;C	57;57;57	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3460	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1885	228.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	782	784	GAA	300;294;297	G,A;A;A	299,1;294;297	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3460	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1885	228.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	1070	1072	GAT	301;301;302	G;A;T	301;301;302	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3460	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1885	228.8	0	.	p	.	0	G140R	NONSYN	418	420	GGA	1088	1090	AGA	305;302;300	A;G;A	305;302;300	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3460	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1885	228.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1193	1195	TCA	350;352;355	T;C;A	350;352;355	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3460	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1885	228.8	0	.	p	.	0	F215S	NONSYN	643	645	TTT	1313	1315	TCT	284;278;281	T;C;T	284;278;281	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3460	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1885	228.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1322	1324	GTC	277;277;275	G;T,C;C	277;275,2;275	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3460	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1885	228.8	0	.	p	.	0	R258H	NONSYN	772	774	CGT	1442	1444	CAT	296;295;296	C,T;A;T	295,1;295;296	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3460	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1885	228.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1652	1654	GCA	274;277;274	G,T;C,T;A	273,1;276,1;274	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3460	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1885	228.8	1	SNP	p	G120K	1	.	.	358	360	AAG	1028	1030	AAG	296;294;293	A,C;A,C;G,T,C	295,1;293,1;291,1,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3460	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1885	228.8	1	SNP	p	D121N	0	.	.	361	363	GAC	1031	1033	GAC	290;290;288	G;A,C;C	290;289,1;288	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3460	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1885	228.8	1	SNP	p	A121D	1	.	.	361	363	GAC	1031	1033	GAC	290;290;288	G;A,C;C	290;289,1;288	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11588	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5402	268.0	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2300	2302	CAT	318;314;314	C,A;A;T	317,1;314;314	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1648	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1623	126.4	1	SNP	p	V57M	1	.	.	169	171	ATG	937	939	ATG	318;321;319	A;T,C,A;G,C	318;319,1,1;318,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
